Cargando…

Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia

BACKGROUND: Cefiderocol is a novel siderophore cephalosporin, developed for activity against MDR Gram-negative bacilli (MDR-GNB). OBJECTIVES: To assess the in vitro antibacterial activity of cefiderocol against a collection of MDR-GNB clinical isolates from hospitals in southern Spain. METHODS: Two...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delgado-Valverde, Mercedes, Conejo, M del Carmen, Serrano, Lara, Fernández-Cuenca, Felipe, Pascual, Álvaro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7303814/ https://www.ncbi.nlm.nih.gov/pubmed/32277821 http://dx.doi.org/10.1093/jac/dkaa117

Ejemplares similares

2790. Activity of Cefiderocol and Comparator Agents Against Pediatric Isolates of Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia from the SENTRY Surveillance Program (2020-2022)
por: Nguyen, Sean T, et al.
Publicado: (2023)

Activity of Cefiderocol Against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Endemic to Medical Centers in New York City
por: Iregui, Alejandro, et al.
Publicado: (2020)

In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia
por: Nakamura, Rio, et al.
Publicado: (2021)

Successful Treatment of Persistent Stenotrophomonas maltophilia Bacteremia With Cefiderocol in an Infant
por: Hsu, Alice J, et al.
Publicado: (2023)

Inactivation of Opportunistic Pathogens Acinetobacter baumannii and Stenotrophomonas maltophilia by Antimicrobial Photodynamic Therapy
por: Buchovec, Irina, et al.
Publicado: (2022)

Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
por: Petraitis, Vidmantas, et al.
Publicado: (2022)

Cefiderocol for Stenotrophomonas maltophilia prosthetic joint infection: a case report
por: Chambers, MaKenzie M., et al.
Publicado: (2023)

1366. In Vitro and In Vivo Activity of Cefiderocol against Stenotrophomonas maltophilia Clinical Isolates
por: Ito, Akinobu, et al.
Publicado: (2018)

Evolution of cefiderocol resistance in Stenotrophomonas maltophilia using in vitro serial passage techniques
por: Werth, Brian J., et al.
Publicado: (2022)

1065. Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits
por: Petraitis, Vidmantas, et al.
Publicado: (2021)

2752. Outcomes of Patients with Stenotrophomonas maltophilia infections treated with Cefiderocol in PROVE (Retrospective Cefiderocol Chart Review) Study
por: Marcella, Stephen, et al.
Publicado: (2023)

2791. Antimicrobial Activity of Cefiderocol and Comparator Agents Against Isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia by Infection Type from United States Hospitals in the SENTRY Antimicrobial Surveillance Program (2020-2022)
por: Nguyen, Sean T, et al.
Publicado: (2023)

Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
por: Biagi, M., et al.
Publicado: (2020)

Risk Factors and Outcomes of Stenotrophomonas maltophilia Bacteraemia: A Comparison with Bacteraemia Caused by Pseudomonas aeruginosa and Acinetobacter Species
por: Hotta, Go, et al.
Publicado: (2014)

Multidrug-Resistant Acinetobacter baumannii Clone, France
por: Bonnin, Rémy A., et al.
Publicado: (2013)

Acinetobacter baumannii and Cefiderocol, between Cidality and Adaptability
por: Stracquadanio, Stefano, et al.
Publicado: (2022)

Cefiderocol as a Treatment Option for Stenotrophomonas maltophilia Causing Hospital-Acquired/Ventilator-Associated Pneumonia
por: Rashid, Muhammad Humayoun, et al.
Publicado: (2023)

Resurgence of Global Opportunistic Multidrug-resistant Stenotrophomonas maltophilia
por: Gupta, Pradheer, et al.
Publicado: (2018)

645. Trends in the Susceptibility of US Acinetobacter baumannii-calcoaceticus Species Complex and Stenotrophomonas maltophilia Isolates to Minocycline, 2014-2021
por: Shortridge, Dee, et al.
Publicado: (2022)

Acinetobacter baumannii response to cefiderocol challenge in human urine
por: Nishimura, Brent, et al.
Publicado: (2022)

Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii
por: Raro, Otávio Hallal Ferreira, et al.
Publicado: (2023)

Antimicrobial Susceptibility of Acinetobacter calcoaceticus–Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997–2016)
por: Gales, Ana C, et al.
Publicado: (2019)

The Effects of Antibiotic Combination Treatments on Pseudomonas aeruginosa Tolerance Evolution and Coexistence with Stenotrophomonas maltophilia
por: Law, Jack P., et al.
Publicado: (2022)

Stenotrophomonas maltophilia in Salad
por: Qureshi, Andleeb, et al.
Publicado: (2005)

Stenotrophomonas maltophilia pericarditis
por: Avşar, Cansu Bulut, et al.
Publicado: (2017)

Socioeconomic burden of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in Korea
por: Kim, Chung-Jong, et al.
Publicado: (2022)

Quorum Sensing Signaling and Quenching in the Multidrug-Resistant Pathogen Stenotrophomonas maltophilia
por: Huedo, Pol, et al.
Publicado: (2018)

The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
por: Gröschel, Matthias I., et al.
Publicado: (2020)

Multidrug-Resistant Stenotrophomonas maltophilia Keratitis in a Penetrating Keratoplasty Patient
por: Thakral, Nikhil, et al.
Publicado: (2021)

Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm
por: Pompilio, Arianna, et al.
Publicado: (2015)

Pseudomonas aeruginosa Promotes Persistence of Stenotrophomonas maltophilia via Increased Adherence to Depolarized Respiratory Epithelium
por: McDaniel, Melissa S., et al.
Publicado: (2022)

Multidrug-resistant Acinetobacter baumannii clones persist on hospital inanimate surfaces
por: Rocha, Igor Vasconcelos, et al.
Publicado: (2018)

2174. Cefiderocol Activity Against Multidrug-resistant and Molecularly Characterized Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus complex Clinical Isolates Causing Infection in United States Hospitals (2020–2022)
por: Mendes, Rodrigo E, et al.
Publicado: (2023)

The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection
por: Mwangi, James, et al.
Publicado: (2019)

Effect of Stenotrophomonas maltophilia on Tuberculosis
por: Li, Yue, et al.
Publicado: (2023)

Identification and Characterization of a Serious Multidrug Resistant Stenotrophomonas maltophilia Strain in China
por: Zhao, Yan, et al.
Publicado: (2015)

Necrotizing Pancreatitis Infected with Stenotrophomonas maltophilia: An Emerging Rare Multidrug-Resistant Organism
por: Dar, Sophia, et al.
Publicado: (2023)

A Patient Presenting with Cholangitis due to Stenotrophomonas Maltophilia and Pseudomonas Aeruginosa Successfully Treated with Intrabiliary Colistine
por: Pérez, Pablo N., et al.
Publicado: (2014)

Effectors of the Stenotrophomonas maltophilia Type IV Secretion System Mediate Killing of Clinical Isolates of Pseudomonas aeruginosa
por: Nas, Megan Y., et al.
Publicado: (2021)

2751. Cefiderocol Use in Treating Patients with Confirmed Stenotrophomonas maltophilia Infections in US Hospitals During January 2020 - June 2022
por: Cai, Bin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5olktdlm4iotafjvq3dv9uo65c